{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670319806269568.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1111/j.1572-0241.2006.00418.x"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/10.1111/j.1572-0241.2006.00418.x"}},{"identifier":{"@type":"NAID","@value":"30010262962"}}],"dc:title":[{"@value":"Treatment with Peg-Interferon alpha-2b for HBeAg-Positive Chronic Hepatitis B: HBsAg Loss Is Associated with HBV Genotype"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670319806269444","@type":"Researcher","foaf:name":[{"@value":"Hajo J. Flink"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319806269442","@type":"Researcher","foaf:name":[{"@value":"Monika van Zonneveld"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319806269441","@type":"Researcher","foaf:name":[{"@value":"Bettina E. Hansen"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319806269440","@type":"Researcher","foaf:name":[{"@value":"Robert A. de Man"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319806269443","@type":"Researcher","foaf:name":[{"@value":"Solko W. Schalm"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319806269568","@type":"Researcher","foaf:name":[{"@value":"Harry L.A. Janssen"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00029270"},{"@type":"EISSN","@value":"15720241"}],"prism:publicationName":[{"@value":"The American Journal of Gastroenterology"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2006-02","prism:volume":"101","prism:number":"2","prism:startingPage":"297","prism:endingPage":"303"},"reviewed":"false","url":[{"@id":"https://journals.lww.com/10.1111/j.1572-0241.2006.00418.x"}],"createdAt":"2006-02-02","modifiedAt":"2022-01-26","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004232550879360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The response to interferon is influenced by hepatitis B virus genotype in vitro and in vivo"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235757163264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204792984064","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"日本肝臓学会コンセンサス神戸2009：C型肝炎の診断と治療"},{"@language":"en","@value":"JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis C"},{"@language":"ja-Kana","@value":"ニホン カンゾウ ガッカイ コンセンサス コウベ 2009 Cガタ カンエン ノ シンダン ト チリョウ"},{"@value":"日本肝臓学会コンセンサス神戸2009--B型肝炎の診断と治療"},{"@language":"ja-Kana","@value":"ニホン カンゾウ ガッカイ コンセンサス コウベ 2009 Bガタ カンエン ノ シンダン ト チリョウ"},{"@value":"JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679846902528","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Membranous Nephropathy Associated with Chronic Hepatitis B Occurring in a Short Period After Acute Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681218742528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Correlation between Hepatitis B Virus Genotypes and Clinical Outcomes"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681377615360","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"B型肝炎の治療-遺伝子型と治療について-"},{"@language":"en","@value":"Therapy for chronic hepatitis B: relationship between HBV genotype and efficacy or resistance of anti-viral therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1570009750573172608","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Hepatitis B virus genotypes in Europe"}]},{"@id":"https://cir.nii.ac.jp/crid/1570291226268024064","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"New scoring system for predicting relapse after lamivudine-induced hepatitis B e-antigen loss in chronic hepatitis B patients"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1111/j.1572-0241.2006.00418.x"},{"@type":"CIA","@value":"30010262962"},{"@type":"CROSSREF","@value":"10.1111/j.1872-034x.2010.00739.x_references_DOI_4i6IVb2ZCNZyDVmHaza0rQd952x"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.49.2812_references_DOI_4i6IVb2ZCNZyDVmHaza0rQd952x"},{"@type":"CROSSREF","@value":"10.7883/yoken.65.476_references_DOI_4i6IVb2ZCNZyDVmHaza0rQd952x"},{"@type":"CROSSREF","@value":"10.2957/kanzo.51.243_references_DOI_4i6IVb2ZCNZyDVmHaza0rQd952x"},{"@type":"CROSSREF","@value":"10.1016/j.virusres.2012.10.027_references_DOI_4i6IVb2ZCNZyDVmHaza0rQd952x"}]}